Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human LIAS Protein, N-His

Catalog #:   YHA77601 Specific References (49) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: O43766
Protein length: Met86-Tyr309
Overview

Catalog No.

YHA77601

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Met86-Tyr309

Predicted molecular weight

26.93 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

O43766

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

LS, LAS, Lipoic acid synthase, Lipoyl synthase, mitochondrial, Lipoate synthase, Lip-syn, LIAS

Data Image
  • SDS-PAGE
    SDS PAGE for Recombinant Human LIAS Protein
References

Cuproptosis-related gene signatures define the immune microenvironment in diabetic nephropathy., PMID:40460381

Clinically Relevant Cutoffs for Anti-Extractable Nuclear Antigen Line Immunoassays., PMID:40460086

[Effect and mechanism of Shenmai Injection in regulating copper death in myocardial fibrosis in rats]., PMID:40350947

Discovery of Cu(II)-Dipyridophenazine Complex for Synergistic Cuproptosis/Chemodynamic Therapy via Disrupting the Tricarboxylic Acid (TCA) Cycle in Metastatic TNBC., PMID:40348584

α-Synuclein targeted therapy with multiple pathological improvement for Parkinson's disease by macrocyclic amphiphile nanomedicine., PMID:40319681

Nanocatalytic system releases overloaded zinc ions and ROS to induce Znproptosis and interrupt cell cycle through inhibiting Akt/mTOR pathway., PMID:40225560

A novel anti-C6 based approach for IgG avidity testing in Lyme borreliosis: A proof-of-concept study., PMID:40188988

Identification of a Novel Antagonist of BRS-3 from Natural Products and Its Protective Effects Against H2O2-Induced Cardiomyocyte Injury., PMID:40141387

Knocking Down Ferredoxin 1 Inhibits the Progression of Colorectal Cancer and Regulates Cuproptosis via Mediating the Hippo Signaling Pathway., PMID:39987563

Evolocumab attenuates myocardial ischemia/reperfusion injury by blocking PCSK9/LIAS-mediated cuproptosis of cardiomyocytes., PMID:39930254

Peripheral mitochondrial transplantation alleviates diabetes-associated cognitive dysfunction by suppressing cuproptosis., PMID:39924054

Cuproptosis gene characterizes the immune microenvironment of diabetic nephropathy., PMID:39892769

Characterization of tumor prognosis and sensitive chemotherapy drugs based on cuproptosis-related gene signature in ovarian cancer., PMID:39849417

A comparative study evaluating three line immunoassays available for serodiagnosis of equine Lyme borreliosis: Detection of Borrelia burgdorferi sensu lato-specific antibodies in serum samples of vaccinated and non-vaccinated horses., PMID:39715214

Identification of cuproptosis-related genes in septic shock based on bioinformatic analysis., PMID:39652607

Immunogenicity Assessment of a 14-Valent Human Papillomavirus Vaccine Candidate in Mice., PMID:39591165

[The role of peritumoral electroacupuncture in regulating cuproptosis for sensitization of chemotherapy efficacy in mice with triple-negative breast cancer]., PMID:39557431

Engineered bacterial lipoate protein ligase A (lplA) restores lipoylation in cell models of lipoylation deficiency., PMID:39547509

LiaR-dependent gene expression contributes to antimicrobial responses in group A Streptococcus., PMID:39535201

Rhomboid-like 2 correlated with TME infiltration inhibits cuproptosis-related genes and drives malignant phenotype in clear cell renal cell carcinoma., PMID:39511359

Germline genetic variants in a case of familial cancer: RAD51D and four other co-segregated variants., PMID:39445568

Comprehensive analysis of the expression level, prognostic value, and immune infiltration of cuproptosis-related genes in human breast cancer., PMID:39432636

Identification of potential biomarkers of cuproptosis in cerebral ischemia., PMID:39360273

Bovine serum albumin-bound homologous targeted nanoparticles for breast cancer combinatorial therapy., PMID:39343270

Case report: Unveiling genetic and phenotypic variability in Nonketotic hyperglycinemia: an atypical early onset case associated with a novel GLRX5 variant., PMID:39323869

Acute inhibition of iron-sulfur cluster biosynthesis disrupts metabolic flexibility in mice., PMID:39229169

Rational structure-guided design of a blood stage malaria vaccine immunogen presenting a single epitope from PfRH5., PMID:39223355

Triptolide-induced cuproptosis is a novel antitumor strategy for the treatment of cervical cancer., PMID:39198750

Risk factor prediction and immune correlation analysis of cuproptosis-related gene in osteoarthritis., PMID:39087591

Cuproptosis, the novel type of oxidation-induced cell death in thoracic cancers: can it enhance the success of immunotherapy?, PMID:39068453

Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype., PMID:39059380

Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies., PMID:39019011

FDX1 as a novel biomarker and treatment target for stomach adenocarcinoma., PMID:38983344

Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex., PMID:38849365

Identification of 10 differentially expressed and cuproptosis-related genes in immune infiltration and prognosis of thyroid carcinoma., PMID:38650151

LiaR-dependent gene expression contributes to antimicrobial responses in group A Streptococcus., PMID:38617309

Bioinformatics-based dynamics of cuproptosis -related indicators in experimental silicosis., PMID:38564864

[Correlation of serum ferredoxin 1 and lipoic acid levels with severity of coronary artery disease]., PMID:38501416

Identification and validation of a novel cuproptosis signature for stratifying different prognostic, immune, metabolic, and therapeutic landscapes in pancreatic adenocarcinoma., PMID:38497885

CRYL1 is a Potential Prognostic Biomarker of Clear Cell Renal Cell Carcinoma Correlated with Immune Infiltration and Cuproptosis., PMID:38497139

Assessing the sensitivity and specificity of myositis-specific and associated autoantibodies: a sub-study from the MyoCite cohort., PMID:38479813

Association of Systemic Markers of Inflammation with Signs and Symptoms of Dry Eye Disease and Sjogren's Syndrome in the Dry Eye Assessment and Management (DREAM©) Study., PMID:38345056

Analyses of human vaccine-specific circulating and bone marrow-resident B cell populations reveal benefit of delayed vaccine booster dosing with blood-stage malaria antigens., PMID:38299155

Two-component system LiaSR negatively regulated the acid resistance and pathogenicity of Listeria monocytogenes 10403S., PMID:38225058

A novel cuproptosis-related prognostic gene signature in adrenocortical carcinoma., PMID:37997497

Identification of 6 cuproptosis-related genes for active ulcerative colitis with both diagnostic and therapeutic values., PMID:37904461

Exploring the role of LIAS-related cuproptosis in systemic lupus erythematosus., PMID:37903189

Comprehensive analysis of cuproptosis genes and cuproptosis-related genes as prognosis factors in esophageal squamous cell carcinoma., PMID:37866660

Bioinformatics analysis of copper death gene in diabetic immune infiltration., PMID:37773841

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human LIAS Protein, N-His [YHA77601]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only